On May 16, the share price of Haite Biotech (300683) fell sharply. As of 14:53, Haite Biotech fell by 5%crashtime5undercover.02%, reported at 26.86 yuan/share, with a turnover of 161 million yuan, a turnover rate of 4.78%, and an amplitude of 6.82%.

capital trends

As of press time, Haite Biotech has received a main net outflow of 13.95 million yuan, including 10.5 million yuan from ultra-large orders and 3.44 million yuan from large orders. Data showed that the stock's net inflow today was 23.09 million yuan lower than the average net inflow in the past five days.

In terms of northbound funds, Haite Biotech obtained a reduction of 312,300 shares from Northbound Capital on May 14. As of May 14, Northbound Capital currently holds a total of 833,700 shares of Haite Biotech, with a market value of 22.39 million yuan, and its shareholding accounts for outstanding shares. The ratio is 0.63%.

Main business and performance

Haite Biotech's main business is innovative biopharmaceuticalcrashtime5undercoverR & D, production and sales of small molecule chemicals and pharmaceuticals, and also provides related services such as research and development of small molecule chemicals and pharmaceuticals, entrusted drug production.

The latest financial report shows that in the first quarter of this year, Haite Biotech achieved operating income of 132 million yuan, a year-on-year decrease of 4.87%, net profit of-16.5455 million yuan, a year-on-year decrease of 1,024.00%, and basic earnings per share of-0.13 yuan.

(The above content is Tencent's self-selected shares based on public information and intelligently generated by programs or algorithms. It is only used as a reference for users to watch the market, and is not used as investment advice or trading basis. The stock market is risky, please make decisions carefully.)